Drug intelligence / Profile preview

beclomethasone + lidocaine + phenylephrine

Development stage
Unknown
Lead developer
Rebrace Pharmaceuticals
Modality
Small Molecules
Administration
Topical, Rectal
01

Overview

Pilohenz ANO Cream is a topical combination therapy developed by Rebrace Pharmaceuticals for the treatment of hemorrhoids (piles) and anal fissures. The formulation contains three active pharmaceutical ingredients: beclomethasone dipropionate, a potent corticosteroid that reduces inflammation, swelling, and itching; phenylephrine hydrochloride, a sympathomimetic amine that acts as a vasoconstrictor to shrink swollen blood vessels in the anorectal area; and lidocaine (lignocaine) hydrochloride, a local anesthetic that provides rapid relief from pain and discomfort. The cream is designed for topical application to the affected area to manage symptoms associated with inflammatory anorectal conditions.

Brand names
Pilohenz ANO Cream
Other names
beclomethasone dipropionate + lidocaine hydrochloride + phenylephrine hydrochloridebeclomethasone dipropionate + lignocaine hydrochloride + phenylephrine hydrochloride
02

Targets

GR (Glucocorticoid receptor)ADRA1A (α1A)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on beclomethasone + lidocaine + phenylephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on beclomethasone + lidocaine + phenylephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call